Adam Mathias

Adam Mathias is an experienced professional in business assessment and strategic planning, currently serving as a Director at Pfizer in Commercial Strategy & Innovation, focusing on rare diseases. Previously, Adam held various roles including Senior Manager and Director in Business Assessment at Pfizer and worked as a Management Consultant at inVentiv Health Consulting. With a background in clinical research as a Clinical Research Associate at Allergan and a robust educational foundation that includes an MBA from Boston University and a BA in Business Economics and Chemistry from the University of California, Santa Barbara, Adam combines expertise in healthcare and strategic insights to enhance patient outcomes and inform healthcare decisions.